Discover
FMS
Fresenius Medical Care AG & Co. KGaA
23.87
1 x 21.31
1 x 24.34
bid
ask
-
0.48
1.97%
1 @ 04:00 PM
23.87 +0.00 (0.00%)
| Ytd | 0.21% | |
| 1y | -1.00% |
23.84
day range
24.54
20.02
52 week range
27.64
| Open | 24.36 | Prev Close | 24.35 | Low | 23.84 | High | 24.54 | Mkt Cap | 12.82B |
| Vol | 0.00 | Avg Vol | 758.94K | EPS | 2.66 | P/E | 8.97 | Forward P/E | 6.69 |
| Beta | 0.84 | Short Ratio | 4.51 | Inst. Own | 9.74% | Dividend | 0.87 | Div Yield | 3.59 |
| Ex Div Date | 05-22 | Earning | 08-04 | 50-d Avg | 23.55 | 200-d Avg | 23.31 | 1yr Est | 25.75 |
| Income Statement | |||
| Total Revenue | 4.86B | ||
| Revenues (USD) | 5.52B | ||
| Cost of Revenue | 3.55B | ||
| Gross Profit | 1.31B | ||
| Operating Expenses | 802.87M | ||
| Research and Development Expense | 39.63M | ||
| Selling, General and Administrative Expense | 736.01M | ||
| Operating Income | 507.11M | ||
| Interest Expense | 97.55M | ||
| Income Tax Expense | 89.83M | ||
| Net Income | 218.38M | ||
| Net Income Common Stock | 218.38M | ||
| Net Income Common Stock (USD) | 248.16M | ||
| Consolidated Income | 293.17M | ||
| Net Income to Non-Controlling Interests | 74.79M | ||
| Earnings per Basic Share | 0.41 | ||
| Earnings per Basic Share (USD) | 0.46 | ||
| Earnings per Diluted Share | 0.41 | ||
| Dividends per Basic Common Share | 0.61 | ||
| Earning Before Interest & Taxes (EBIT) | 405.76M | ||
| Earning Before Interest & Taxes (USD) | 461.09M | ||
| Weighted Average Shares | 270.09M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.06B | ||
| Cash and Equivalents (USD) | 1.21B | ||
| Investments | 1.05B | ||
| Investments Current | 388.10M | ||
| Investments Non-Current | 660.69M | ||
| Trade and Non-Trade Receivables | 3.38B | ||
| Current Assets | 7.69B | ||
| Property, Plant & Equipment Net | 6.43B | ||
| Total Assets | 31.29B | ||
| Debt Current | 4.65B | ||
| Total Debt | 13.51B | ||
| Current Liabilities | 7.18B | ||
| Debt Non-Current | 8.85B | ||
| Total Liabilities | 17.76B | ||
| Accumulated Retained Earnings (Deficit) | 12.09B | ||
| Accumulated Other Comprehensive Income | -1.31B | ||
| Shareholders Equity | 12.56B | ||
| Shareholders Equity (USD) | 14.27B | ||
| Assets Non-Current | 23.60B | ||
| Total Debt (USD) | 15.35B | ||
| Goodwill and Intangible Assets | 15.25B | ||
| Inventory | 2.33B | ||
| Liabilities Non-Current | 10.58B | ||
| Trade and Non-Trade Payables | 891.84M | ||
| Tax Assets | 509.09M | ||
| Tax Liabilities | 1.03B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 363.11M | ||
| Net Cash Flow from Financing | -769.53M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -177.89M | ||
| Capital Expenditure | -235.35M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -2.62M | ||
| Issuance (Purchase) of Equity Shares | -144.64M | ||
| Issuance (Repayment) of Debt Securities | -147.03M | ||
| Net Cash Flow from Investing | -270.76M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -32.79M | ||
| Net Cash Flow from Operations | 860.30M | ||
| Effect of Exchange Rate Changes on Cash | 2.10M | ||